Guardant Health Appoints Former Dexcom CEO to Board and Names New Chief Accounting Officer

Guardant Health announced two key leadership appointments effective November 2, 2026. Kevin R. Sayer, the former CEO and current Executive Chairman of Dexcom, has been appointed to the Board of Directors. Additionally, Robert A. Parks has been appointed as the company's new Chief Accounting Officer.

Key Details

• Director Appointment: Kevin R. Sayer was appointed as a Class II director, increasing the board's size to 11. His term will expire at the 2029 Annual Meeting of Stockholders.
• Director Compensation: Mr. Sayer will receive an initial restricted stock unit award valued at $500,000, vesting over three years, and an annual cash retainer of $60,000.
• Officer Appointment: Robert A. Parks was named Chief Accounting Officer and principal accounting officer. He previously served as Chief Accounting Officer at companies including Fortrea Holdings Inc., NetApp, Inc., and Syneos Health, Inc.